Menu

Jumping Genes Inactivated with CRISPR in Pigs

The study could pave the way for transplanting porcine organs to humans without the risk of reigniting endogenous retroviruses.

Aug 10, 2017
Shawna Williams

Piglets whose genes were altered using CRISPREGENESISThe gene-editing technique CRISPR-Cas9 has received ample attention for its potential to improve human health via gene therapy. Today (August 10), an international team of researchers announced a step toward giving it an entirely different role in medicine: enabling xenotransplantation—in this case, of pig organs into humans. As reported in Science, the group used CRISPR to disable viral DNA lodged in the pig genome and then grew healthy piglets from the edited cells.

Pig organs are about the same size as humans,’ so some scientists and transplant surgeons see them as candidates to solve the problem of a shortage of organ donors, reports The New York Times. Previous experiments have worked toward customizing pig organs to make them compatible with human recipients. But one concern has been the potential for the zombies of pig infections past, known as porcine endogenous retroviruses (PERVs), to reanimate and infect human organ recipients.

See “Scientists Create First Human-Pig Chimeric Embryos”

The research group identified 25 PERVs in pig genomes, then used CRISPR-Cas9 to inactivate all of them. They inserted the edited genetic material into pig eggs to create embryos, which were implanted in sows and developed into piglets, reports New Scientist.

“This research represents an important advance in addressing safety concerns about cross-species viral transmission,” study author Luhan Yang of the biotech company eGenesis tells The Guardian. “Our team will further engineer the Perv-free pig strain to deliver safe and effective xenotransplantation.”

The New York Times notes that patients with diabetes have been treated with pig pancreatic cells, and burn victims with pig skin grafts, with no apparent problems so far caused by PERVs.

Jay Fishman, co-director of the transplant program at Massachusetts General Hospital, questions whether PERVs were really so dangerous in the first place. “We don’t know that if we transplant pig organs with the viruses that they will transmit infections, and we don’t know that the infections are dangerous,” he tells the Times. “I think the risk to society is very low.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!